0.00Open0.26Pre Close0 Volume470 Open Interest10.00Strike Price0.00Turnover34.20%IV3.28%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type-0.4238Delta0.7181Gamma57.54Leverage Ratio-0.0115Theta-0.0010Rho-24.39Eff Leverage0.0063Vega
KKR Real Estate Finance Trust Stock Discussion
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet